Company Overview

GE HealthCare Technologies Inc. is a leading medical technology firm, holding significant market share in imaging and ultrasound equipment. Formerly known as GE Healthcare Holding LLC, the company has established itself as a comprehensive healthcare solutions provider. Based in Chicago, Illinois, it offers innovative medical technology, pharmaceutical diagnostics, and integrated AI-enabled solutions globally.

Business Overview

GE HealthCare Technologies Inc. develops, manufactures, and markets products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients across the United States, Canada, and internationally. The company operates through four distinct business segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

Business Segments (2024 Revenue Share)

- Imaging (45% of revenue): This segment provides advanced imaging technologies including molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products.

- Advanced Visualization Solutions (AVS) (26% of revenue): AVS focuses on ultrasound, image-guided therapies, and interventional solutions crucial for screening, diagnosis, treatment, and monitoring of various diseases across clinical areas like women's health, cardiovascular, and comprehensive care.

- Patient Care Solutions (PCS) (16% of revenue): PCS offers a range of medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring systems, diagnostic cardiology equipment, consumables and services, digital health solutions, maternal and infant care products, and anesthesia devices.

- Pharmaceutical Diagnostics (13% of revenue): This segment supplies diagnostic agents for CT, angiography, X-ray, MR, SPECT, and PET imaging. It also provides contrast media pharmaceuticals to enhance visibility during diagnostic scans and molecular imaging agents or radiopharmaceuticals.

Geographic Revenue Distribution

The company's sales exhibit strong geographic diversity:

- United States: 46%

- EMEA (Europe, Middle East, Africa): 26%

- Rest of the World: 17%

- China: 12%

In 2023, the company reported 42% of its revenue from the United States and 13% from China, where it faces increasing competition. GE HealthCare operates in over 100 countries.

Financial Performance

Recent Financial Results (Q2 2025 - as of July 30, 2025)

- Revenue: $5.0 billion (3% reported, 2% Organic\* growth year-over-year).

- Adjusted Earnings Per Share (EPS): $1.06 (beat Zacks Consensus Estimate of $0.91 by 16.5%, up 6% year-over-year).

- GAAP EPS: $1.06 (up 13.9% from the prior year).

- Net Income Margin: Increased to 9.7% from 8.9% in the prior year.

- Diluted EPS: Rose to $1.06 from $0.93 in the previous year.

Annual Performance (FY 2024)

- Revenue: $19.67 billion (an increase of 0.61% compared to $19.55 billion in FY 2023).

- Earnings: $1.99 billion (an increase of 43.90% year-over-year).

Operational Highlights

- Recurring Revenue: Approximately half of GE HealthCare's revenue is recurring, comprising servicing (around one-third), pharmaceutical diagnostics (10%-15%), and digital solutions (just over 5%). This model provides stability and predictable cash flows.

- Innovations & Deals (2024): The company introduced approximately 40 innovations and closed over 50 strategic enterprise deals globally, establishing a solid foundation for future growth.

2025 Guidance (Updated July 30, 2025)

GE HealthCare has raised its full-year 2025 guidance:

- Organic Revenue Growth: Expected to be approximately 3% year-over-year.

- Adjusted EBIT Margin: Projected between 15.2% and 15.4%.

- Adjusted EPS: Forecasted in the range of $4.43 to $4.63.

- Free Cash Flow: Anticipated to be at least $1.4 billion.

Global Operations & Innovation

GE HealthCare maintains major regional operations in key global hubs including Buc (France), Helsinki (Finland), Kraków (Poland), Budapest (Hungary), Yizhuang (China), Hino & Tokyo (Japan), and Bangalore (India). Its largest R&D center is located in Bangalore, India, built at a cost of $50 million. The company continues to invest significantly in artificial intelligence and digital solutions to advance its precision care capabilities. GE HealthCare's primary customers are hospitals and health networks worldwide.

Market Position

GE HealthCare Technologies Inc. currently holds a market capitalization of ‪34.20 B‬. The company maintains a strong competitive standing across its key segments, particularly in medical imaging, where it is a global market share leader. GE HealthCare Technologies represents a robust healthcare technology platform characterized by diversified revenue streams, a significant recurring revenue component, and substantial investments in next-generation solutions such as AI-enabled diagnostics and precision care technologies.